Delivery Order SPE2DB20D9331-SPE2DB22FL0L5
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $49,531.40 firm fixed-price delivery order is for the supply of 4,565,482,195 units of the medication ONCASPAR 3,750 UNIT/5 ML VIAL 5ML. The contract is not associated with a set-aside designation. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award with ID SPE2DX15D9114|SPE2DX22F5ZUF was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $86,440.56 firm fixed-price delivery order is for the supply of 3,750 units of the medication ONCASPAR 3,750 UNIT/5 ML VIAL 5ML. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $124,396.08 firm fixed-price delivery order is for the supply of 4,554,408,511 units of the oncology drug ONCASPAR (3,750 unit/5 mL vial, 5 mL) to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger $499,999,999 indefinite delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $49,531.40 firm fixed-price delivery order is for the supply of 3,750 units of the drug ONCASPAR in 5 ml vials to support the recurring medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $49,531.40, is a firm fixed-price delivery order for 4,560,593,542 units of the prescription drug ONCASPAR (3,750 units/5 ml vial, 5 ml). The contract is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a larger single-award Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $82,930.72 delivery order is for 3,750 units of the oncology medication ONCASPAR in 5 ML vials. The award is under a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 between DMS Pharmaceutical Group and the DLA, which enables the DLA to issue delivery orders for a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $41,494.84 firm fixed-price delivery order is for the supply of 4,556,227,681 units of the prescription drug ONCASPAR (3,750 units/5 mL vial) to support the medical needs of the Department of Defense (DoD) healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery...
- This federal contract award, valued at $82,930.72, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,555,565,043 units of the oncology drug ONCASPAR in 5 ml vials. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December...
- This federal contract award, valued at $86,440.56, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 4,557,549,804 units of the oncology medication ONCASPAR in 5 ML vials. DMS Pharmaceutical Group Inc. holds a single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, with a ceiling value of $43,220.28, is a firm fixed-price delivery order for the supply of 4,556,239,764 units of the oncology drug Oncaspar (pegaspargase) in 5 ml vials. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB22FL0L5Delivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $86,440.56 firm fixed-price delivery order is for the supply of ONCASPAR 3,750 UNIT/5 ML VIAL 5ML, a pharmaceutical product, to support the medical supply needs of Department of Defense (DoD) healthcare facilities. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This single-award IDC enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical items, from common medications to specialized drugs and medical supplies, to fulfill the recurring medical requirements of military health facilities worldwide. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $86.4k | 1/21/22 |